Atrial Natriuretic Factor (4-28) from multiple species is a shared peptide region used to investigate conserved ligand-binding determinants. Its structure supports studies of structural flexibility and motif placement. Researchers analyze its folding to evaluate comparative receptor affinity. The molecule enriches cross-species natriuretic peptide research.
CAT No: A17047
CAS No:95896-08-5
Synonyms/Alias:Anaritida;95896-08-5;Anaritide;Anaritidum;Anaritidum [Latin];Anaritida [Spanish];Anaritide [INN:BAN];Atrial Natriuretic Factor (4-28) (human, bovine, porcine);UNII-1M00R25BPL;Wy 47,663;1M00R25BPL;DTXSID401336852;AT42476;FA108575;Atrial natriuretic factor(4-28)(human,bovine,porcine);Atriopeptin-21 (rat), N-L-arginyl-8-L-methionine-21a-L-phenylalanine-21b-L-arginine-21c-L-tyrosine-;
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.